# Title
The O
first O
case O
of O
mitochondrial B-Disease
acetoacetyl-CoA B-Disease
thiolase I-Disease
deficiency I-Disease
identified O
by O
expanded O
newborn O
metabolic O
screening O
in O
Italy: O
the O
importance O
of O
an O
integrated O
diagnostic O
approach. O

# Abstract
A O
pilot O
expanded O
newborn O
screening O
programme O
to O
detect O
inherited B-Disease
metabolic I-Disease
disorders I-Disease
by O
means O
of O
liquid O
chromatography O
coupled O
with O
tandem O
mass O
spectrometry O
(LC-MS O
MS) O
began O
in O
the O
Campania O
region, O
southern O
Italy, O
in O
2007. O
By O
October O
2009, O
>8,800 O
dried O
blood O
samples O
on O
filter O
paper O
from O
11 O
hospitals O
had O
been O
screened. O
Within O
this O
screening O
programme, O
we O
identified O
a O
case O
of O
mitochondrial B-Disease
acetoacetyl-coenzyme I-Disease
A I-Disease
(CoA) I-Disease
thiolase I-Disease
deficiency I-Disease
[beta-ketothiolase B-Disease
(beta-KT) B-Disease
deficiency] I-Disease
by O
analysing O
the O
acylcarnitine B-Chemical
profile O
from O
a O
dried O
blood O
spot O
with O
LC-MS O
MS. O
Gas O
chromatography O
coupled O
with O
mass O
spectrometry O
analysis O
of O
urinary O
organic B-Chemical
acids I-Chemical
and O
LC-MS O
MS O
analysis O
of O
urinary O
acylcarnitines B-Chemical
were O
in O
line O
with O
this O
disorder. O
In O
fact, O
concentrations O
were O
well O
beyond O
the O
cut-off O
values O
of O
tiglyl B-Chemical
carnitine, I-Chemical
3-hydroxybutyrylcarnitine B-Chemical
and O
2-methyl-3-hydroxybutyrylcarnitine, B-Chemical
2-methyl-3-hydroxybutyric B-Chemical
acid I-Chemical
and O
tiglyl B-Chemical
glycine. I-Chemical
The O
absence O
of O
2-methylacetoacetic B-Chemical
acid I-Chemical
in O
urine O
may O
be O
attributed O
to: O
(i) O
the O
instability O
of O
this O
beta-ketoacid B-Chemical
because O
it O
undergoes O
spontaneous O
decarboxylation O
to O
2-butanone, B-Chemical
which O
is O
highly O
volatile O
and O
thus O
difficult O
to O
detect, O
and O
(ii) O
the O
good O
health O
of O
the O
patient B-Species
in O
the O
first O
days O
of O
life. O
beta-KT B-Disease
deficiency I-Disease
was O
subsequently O
diagnosed O
in O
the O
patient's B-Species
older O
sister, O
who O
showed O
increased O
levels O
of O
the O
same O
metabolites O
but O
also O
small O
amounts O
of O
2-methylacetoacetic B-Chemical
acid, I-Chemical
which O
is O
considered O
a O
key O
marker O
for O
beta-KT O
diagnosis. O
Genomic O
analysis O
revealed O
mutation O
c.1189C B-DNAMutation
>G I-DNAMutation
in O
exon O
12 O
of O
the O
ACAT1 B-Gene
gene, O
which O
results O
in O
a O
severe O
defect O
because O
of O
the O
p.H397D B-ProteinMutation
amino O
acid O
change O
in O
both O
alleles O
of O
both O
patients. B-Species